The Efficacy of Conventional Screening Versus mHealth Screening in Early Detection of Oral Potentially Malignant Disorders and Oral Cancer Amongst the Rural Population of Varanasi: A Prospective and Blinded Study
- Conditions
- Smoking, CigaretteTobacco UseTobacco SmokingSmoking, TobaccoAlcohol DrinkingBetel Chewer's MucosaSmokingSmokeless Tobacco Hyperkeratosis
- Interventions
- Diagnostic Test: mHealth
- Registration Number
- NCT06535867
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Brief Summary
Mobile health (mHealth) will be used for early detection of oral cancer and pre-cancer lesions, and to improve awareness of oral cancer among the population and knowledge of oral cancer diagnosis among frontline health providers. This program is inclusive of long term surveillance to downstage oral cancer in India
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- All
- Target Recruitment
- 5122
Positive for any one or more of the following:
- All individuals aged above 18 years positive for habits (smoking and smokeless tobacco, chewing betel leaf, areca nut, paan masala, and/or regular use of alcohol)
- Clinical signs/symptoms (non-healing ulcers, white/ red/red & white patches in the mouth, restriction of mouth opening and swelling of the neck)
- All individuals aged above 40 irrespective of habit/oral lesions
- Individuals already diagnosed with oral cancer and undergoing treatment for oral cancer
- Under treatment for tuberculosis or suffering from any acute illness/ debilitating systemic disorders
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description Participants from Varanasi mHealth Participants will be recruited from Varanasi.
- Primary Outcome Measures
Name Time Method Comparison of mHealth with conventional oral cancer screening Up to 5 years To compare the efficacy of conventional screening with mHealth in identification of oral potentially malignant disorders (OPMDs) / oral cancer.
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Memorial Sloan Kettering Cancer Center (All protocol activites)
🇺🇸New York, New York, United States